Download PDF
CC BY-NC-ND 4.0 · Ann Natl Acad Med Sci 2017; 53(03): 140-147
DOI: 10.1055/s-0040-1712756
Original Article

Gene Therapy in India- Current Status

Neha Thakur
Department of Pediatrics, Hind Institute of Medical Sciences, Jodhpur
,
Prerna Batra
University College of Medical Sciences and Guru Tegh Bahadur Hospital, Jodhpur
,
Kuldeep Singh
AIIMS, Jodhpur
,
Piyush Gupta
University College of Medical Sciences and Guru Tegh Bahadur Hospital, Jodhpur
› Author Affiliations
› Further Information
Also available at
  PDF Download Permissions and Reprints

ABSTRACT

Gene therapy is being considered as a promising modality for more than two decades now. It has been used for a number of difficult-to-treat conditions and has shown good results in some of the conditions, but not that effective in some others. Overcoming the initially faced hindrances, the research in the field of gene therapy resurged. India is one the major Asian countries where gene therapy-related research and centers have shown remarkable growth, despite certain constraints faced by the researchers. Current article discusses the different types of gene therapy along with its clinical implications and its current status in Indian context.

Keywords

Gene therapy - India - children


Publication History

Article published online:
09 May 2020

© .

Thieme Medical and Scientific Publishers Private Ltd.
A-12, Second Floor, Sector -2, NOIDA -201301, India

 

  • References

  • 1 Blaese RM, Culver KW, Miller AD, et al (1995). T lymphocyte-directed gene therapy for ADA-SCID: initial trial results after 4 years. Science 270:475-480.
  • 2 Thrasher AJ, Gaspar HB, Baum C, et al (2006). Gene therapy: X-SCID transgene leukaemogenicity. Nature 443(7109): E5-E6.
  • 3 Hacein-Bey-Abina S, Von Kalle C, Schmidt M, et al (2003). LMO2-associated clonal T cell proliferation in two patients after gene therapy for SCIDX1. Science 302: 415–419.
  • 4 Hauswirth WW, Aleman TS, Kaushal S, et al (2008). Treatment of leber congenital amaurosis due to RPE65 mutations by ocular subretinal injection of adenoassociated virus gene vector: short term results of a phase I trial. Hum Gene Ther 19: 979-990.
  • 5 Niidome T, Huang L (2002). Gene therapy progress and prospects: nonviral vectors. Gene Ther 9: 1647-1652.
  • 6 Gupta K, Singh S, Garg KN (2015). Gene therapy in dentistry: tool of genetic engineering. Revisited. Arch Oral Biol 60:439-446.
  • 7 Patil PM, Chaudhari PD, Sahu M, Duragkar NJ (2012). Review article on gene therapy. Intl J Genet 4: 74-79.
  • 8 TaniI J, Faustine B, Sufian JT (2011). Updates on current advances in gene therapy. West Ind Med J 60: 1-9.
  • 9 Campochiaro PA, Nguyen QD, Shah SM, et al (2006). Adenoviral vector-delivered pigment epithelium-derived factor for neovascular-age -related macular degeneration: results of a phase I clinical trial. Hum Gene Ther 17:167-176.
  • 10 Mancuso K, Hauswirth WW, Li Q, et al (2009). Gene therapy for red green colour blindness in adult primates. Nature 8:784
  • 11 Kastrup J, Jorgensen E, Ruck A, et al (2005). Direct intra-myocardial plasmid vascular endothelial growth factor- A165 gene therapy in patients with stable severe angina pectoris A randomized double-blind placebo controlled study: the Euroinject One trial. J Am Coll Cardiol 45:982-988.
  • 12 Kaplitt MG, Feigin A, Tang C, et al (2007). Safety and tolerability of gene therapy with an adeno-associated virus (AAV) borne GAD gene for Parkinson's disease: an open label, phase I trial. Lancet 369:2097-2105.
  • 13 Conner JM, Darracq MA, Roberts J, Tuszynski MH (2001). Nontropic actions of neurotrophins: subcortical nerve growth factor gene delivery reverses age-related degeneration of primate cortical cholinergic innervation. Proc Natl Acad Sci USA 98:1941-1946.
  • 14 Kordower JH, Herzog CD, Dass B, et al (2006). Delivery of neurturin by AAV2 (CERE-120)-mediated gene transfer provides structural and functional neuroprotection and neurorestoration in MPTP-treated monkeys. Ann Neurol 60:706-715.
  • 15 Mattar CN, Waddington SN, Biswas A, et al (2012). The case for intrauterine gene therapy. Best Pract Res Clin Obstet Gynaecol 26:697-709.
  • 16 Kim S, Peng Z, Kaneda Y (2008). Current status of gene therapy in Asia. Mol Ther 16 :237–243.
  • 17 Kochat V, Kanjirakkuzhiyil S, Baligar P, Nagarajan P, Mukhopadhyay A (2015). Donor antigen-primed regulatory T cells permit liver regeneration and phenotype correction in hemophilia A mouse by allogeneic bone marrow stem cells. Stem Cell Res Ther 6:129.
  • 18 Hareendran S, Ramakrishna B, Jayandharan GR (2016). Synergistic inhibition of PARP-1 and NF-κB signaling downregulates immune response against recombinant AAV2 vectors during hepatic gene therapy. Eur J Immunol 46:154-166.
  • 19 Shetty DK, Inamdar MS (2016). Generation of a transgenic human embryonic stem cell line ectopically expressing the endosomal protein Asrij that regulates pluripotency in mouse embryonic stem cells: BJNhem20-Asrij. Stem Cell Res 16:331-333.
  • 20 Misra SK, Moitra P, Kondaiah P, Bhattacharya S (2016). Co-liposomes having anisamide tagged lipid and cholesteryl tryptophan trigger enhanced gene transfection in sigma receptor positive cells. Colloids Surf B Bio-interfaces 142:130-140.
  • 21 Vij M, Natarajan P, Pattnaik BR, et al (2016). Non-invasive topical delivery of plasmid DNA to the skin using a peptide carrier. J Control Release 222:159-168.
  • 22 Hati Boruah JL, Ranjan R, Gogoi H, et al (2016). Effect of co-transfection of antimyostatin shRNA constructs in caprine fetal fibroblast cells. Anim Biotechnol 27:44-51.
  • 23 Kumar VB, Medhi H, Yong Z, Paik P (2016). Designing idiosyncratic hmPCLsiRNA nanoformulated capsules for silencing and cancer therapy. Nanomedicine 12:579-588.
  • 24 Sarkar S, Quinn BA, Shen XN, et al (2015). Therapy of prostate cancer using a novel cancer terminator virus and a small molecule BH-3 mimetic. Oncotarget 6:10712-10727.
  • 25 National Ethical Guidelines for Biomedical and Health Research involving Human Participants, 2017 and the National Guidelines for Stem Cell Research, 2017. Available at http://icmr.nic.in/icmrnews/. Last Accessed 29.09.2016.